Xenon Pharmaceuticals Inc (XENE)
Equity Ratio
95.88%
Quarterly · Period ending:
XENE Equity Ratio
Latest reported95.88%period ending
Latest reported95.88%period ending
XENE Quarterly Equity Ratio (-193.94% → 95.88%)
Latest values, visible window
High-resolution chart · PNG
XENE equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 95.8808% | |
| 96.4674% | |
| 59.2622% | |
| 92.0497% | |
| 94.0228% | |
| 94.7095% | |
| 94.5829% | |
| 95.4428% | |
| 95.4792% | |
| 96.5915% | |
| 96.1777% | |
| 94.859% | |
| 94.3872% | |
| 95.4264% | |
| 95.6707% | |
| 97.0748% | |
| 97.3263% | |
| 97.096% | |
| 96.1584% | |
| 94.1692% | |
| 93.5467% | |
| 95.048% | |
| 90.5749% | |
| 91.41% | |
| 89.8527% | |
| 79.3012% | |
| 62.2741% | |
| 75.3903% | |
| 78.1806% | |
| 80.5875% | |
| 84.372% | |
| 85.2064% | |
| 77.3596% | |
| 75.4674% | |
| 77.9124% | |
| 93.4037% | |
| 93.0402% | |
| 94.0924% | |
| 94.6864% | |
| 94.4638% | |
| 94.5589% | |
| 95.1122% | |
| 95.4417% | |
| 92.158% | |
| 84.084% | |
| 86.8594% | |
| 83.254% | |
| 64.6036% | |
| 53.4509% | |
| 44.2601% | |
| 28.6075% | |
| 28.6075% | |
| 19.94% | |
| -193.9436% |